We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 15.49%
3 Technology 15.18%
4 Industrials 11.77%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPM icon
76
RPM International
RPM
$14.7B
$22.9M 0.34%
500,623
-24,070
-5% -$1.1M
COR icon
77
Cencora
COR
$59.6B
$22.9M 0.34%
295,718
+1,223
+0.4% +$93K
ROP icon
78
Roper Technologies
ROP
$38.8B
$21.5M 0.32%
147,120
-2,530
-2% -$372K
IBM icon
79
IBM
IBM
$222B
$21.3M 0.32%
117,420
-46,935
-29% -$8.55M
JKHY icon
80
Jack Henry & Associates
JKHY
$11.1B
$20.5M 0.31%
367,831
-13,687
-4% -$797K
VFC icon
81
VF Corp
VFC
$5.99B
$17.3M 0.26%
277,940
-3,626
-1% -$217K
COP icon
82
ConocoPhillips
COP
$144B
$16.4M 0.24%
214,097
-13,496
-6% -$1.1M
MKC icon
83
McCormick & Company Non-Voting
MKC
$14B
$14.1M 0.21%
421,022
-324
-0.1% -$11.2K
KMI icon
84
Kinder Morgan
KMI
$69.9B
$13.8M 0.21%
359,001
+292,226
+438% +$11.1M
MDT icon
85
Medtronic
MDT
$110B
$13.5M 0.2%
217,819
+9,497
+5% +$604K
WBA
86
DELISTED
Walgreens Boots Alliance
WBA
$12.2M 0.18%
206,573
+3,965
+2% +$260K
CPT icon
87
Camden Property Trust
CPT
$11B
$11.4M 0.17%
166,900
DVN icon
88
Devon Energy
DVN
$50.8B
$11.4M 0.17%
167,702
+140,181
+509% +$10.4M
VGT icon
89
Vanguard Information Technology ETF
VGT
$147B
$11.4M 0.17%
907,352
+9,480
+1% +$118K
GIS icon
90
General Mills
GIS
$19.3B
$11.1M 0.17%
219,799
-87,189
-28% -$4.57M
VZ icon
91
Verizon
VZ
$195B
$11.1M 0.17%
221,533
+19,692
+10% +$979K
T icon
92
AT&T
T
$160B
$9.73M 0.15%
365,584
-69,747
-16% -$1.86M
XRAY icon
93
Dentsply Sirona
XRAY
$2.86B
$9.38M 0.14%
205,670
+61
+0% +$2.87K
APD icon
94
Air Products & Chemicals
APD
$65.6B
$8.76M 0.13%
72,734
-18,242
-20% -$2.23M
BMY icon
95
Bristol-Myers Squibb
BMY
$135B
$8.58M 0.13%
167,615
-6,560
-4% -$328K
BOKF icon
96
BOK Financial
BOKF
$8.79B
$8.48M 0.13%
127,539
+5,775
+5% +$385K
DSI icon
97
iShares MSCI KLD 400 Social ETF
DSI
$5.54B
$8.06M 0.12%
219,702
-8,270
-4% -$305K
DD
98
DELISTED
Du Pont De Nemours E I
DD
$7.96M 0.12%
116,839
-11,283
-9% -$711K
DCI icon
99
Donaldson
DCI
$11.4B
$7.87M 0.12%
193,742
-3,810
-2% -$155K
ENB icon
100
Enbridge
ENB
$117B
$7.42M 0.11%
155,025
-30,045
-16% -$1.48M

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.